Editorial: Idiopathic Intracranial Hypertension and Low CSF Pressure Headaches

Authors

  • Stewart J. Tepper MD

    Corresponding author
    1. Cleveland Clinic, Cleveland, OH, USA
    • Address all correspondence to Stewart J. Tepper, Cleveland Clinic, Headache Center, C21, 9500 Euclid Avenue, Cleveland, OH 44106, USA.

    Search for more papers by this author

  • Disclosures Stewart J. Tepper, MD
  • Professor of Medicine (Neurology), Cleveland Clinic Lerner College of Medicine, Editor-in-Chief, Headache Currents
  • Grants/Research Support (no personal compensation, all paid to Cleveland Clinic, and not tied to salary):
  • ATI (active), Boston Scientific (active), GSK (active), MAP (active), Merck (active), NuPathe (active), OptiNose (active), Valkee (active), Zogenix (active)
  • All personal compensation <$10,000 per company:
  • Consultant: Allergan (active), ATI (active), Impax (active), MAP (active), Merck (active), Nautilus (active), NuPathe (active), Zogenix (active)
  • Speakers Bureau: Allergan (active), ATI (active), Impax (active), Merck (active), Nautilus (active), Zogenix (active)
  • Advisors Board: Allergan (active), ATI (active), Merck (active), MAP (active), Nautilus (active), NuPathe (active), Pfizer (active), USWorldMeds (active), Zogenix (active)
  • Stock options: ATI (active)
  • Royalties (all active and <$10,000/year): University of Mississippi Press, Peoples PublishingHouse of Peking, Springer

No abstract is available for this article.

Ancillary